Healthcare is an industry fraught with many challenges as well as opportunities.
With the advent of the digital era which has been exponentially accelerated by this pandemic we have a unique opportunity to redefine, redesign and reconfigure global wellness, global health and global health-care delivery systems.
This article will focus on some of the technologies that have not made it to large scale adoption yet, however that have the potential to transform and disrupt the global health and wellness ecosystem.
Specifically, Quantum, Cloud, Edge, Neuromorphic and DNA Computing are intriguing tools in a healthcare futurist’s tech portfolio.
Quantum Computing is focused on principles of quantum theory, with superposition and entanglement features that allow operations to occur at exponential speeds and with lower energy consumption.
Cloud Computing has been on the agenda of several progressive enterprises and as a result the ETF has posted super-sized gains.
Edge Computing is seen as a promising solution to address low network latency, scalability challenges, as well as energy efficiency by pushing specific data elements to the “edge” of the network.
Neuromorphic Computing is an engineering approach that aims to model the complex human brain neuronal networks. It is considered a third generation artificial intelligence tool that blends computer science and neurosciences in order to be more versatile and adaptable.
DNA Computing uses bio-molecular components rather than traditional silicon chips. It enhances computational speed, has less storage requirements and minimal energy requirements.
So what are some of the main challenges that have plagued the healthcare industry and how can these technologies tackle them? Here are a few that rank high on my list: poor interoperability, suboptimal data governance & storage, ongoing adverse side effects due to errors, high costs & long development cycles for research and drug development, slow pace & poor access and lack of scalability for precision medicine solution, ironic lack of a human centric design. Last but not least, redundancy, inefficiency, waste and high costs to society.
While none of these technologies represents a panacea to all these problems, their combined impact could be transformative and lead to an optimised global ecosystem. Quantum Computing could allow extraordinary processing speeds, virtual simulations of scenarios that would otherwise be impossible with traditional computing methods. Cloud- and Edge Computing are also considered major game-changers by increasing access, accuracy, efficiency and agility.
Each one of these could break down silos, enhance connectivity and interoperability. All of them combined could lead to reduced costs, reduced waste and higher efficacy.
DNA computing is often seen as complementary to quantum, however it is more stable and has less of the constraints for large scale deployment. The major advantage outlined by experts is high processing power and parallel computing ability.
As with all technologies, each one of these also has some disadvantages and their large scale deployment will require refinement and time. However, if implemented wisely and with appropriate digital ethics and data governance mechanisms in place they could provide an optimised global health and wellness ecosystem for future generations.
Ingrid Vasiliu-Feltes, MD MBA Is a healthcare executive, futurist and globalist who is highly dedicated to digital and ethics advocacy. She is a Forbes Business Council member, digital strategist, passionate educator and entrepreneurship ecosystem builder, known as an expert speaker, board advisor and consultant. Throughout her career she has received several awards for excellence in research, teaching or leadership. She is the recipient of numerous awards most notably: WBAF World Excellence AwardSocial Entrepreneurship 2021, Top 20 Global Leaders in Digital Twins Technologies, Top 50 Global Leaders in Health Tech,Top 50 Global Ecosystem Leaders, Top 100 Visionary In Education Award 2021, Top 100 Global Women in Leadership Award 2021, Top 100 World Women Vision Award, 2021-Innovation & Tech, Top 100 Women in Social Enterprise 2021 (nominee),Top 50 Global Thinkers (Nominee),Nations of Women Change Makers Award(finalist),Top 100 Healthcare Leader 2020 Award, Top 100 Finance Leader 2020 Award, and Top 100 Women in Crypto 2020. Additionally, she serves as an Expert Advisor to the EU Blockchain Observatory Forum, and was appointed to the Board of UN Legal and Economic Empowerment Network. Dr. Vasiliu-Feltes is CEO of Softhread Inc., the Founder and CEO of The Science, Entrepreneurship and Investments Institute, and currently serving as a Country Director for WBAF USA, Senator of WBAF, Faculty Member of the WBAF Business School-Division of Entrepreneurship, and teaching the Executive MBA Business Technology Course at the UM Business School. She is also acting as the Chief Innovation Officer for the Government Blockchain Association. Most recently she served as President of Detect Genomix, Chief Quality and Safety Officer Chief and Innovation Officer for Mednax, Chief Quality and Safety Officer and Chief of Compliance for the University of Miami UHealth System During her academic tenure she taught several courses within the Medical School, as well as the combined MD/PhD and MD/MPH programs. Throughout her career, Dr. Vasiliu-Feltes held several leadership positions and is a member of numerous prestigious professional organizations. She holds several certifications, such as Bioethics from Harvard, Artificial Intelligence and Business Strategy from MIT Sloan, Blockchain Technology and Business Innovation from MIT Sloan, Finance from Harvard Business School, Negotiation from Harvard Law School, Innovation and Entrepreneurship from Stanford Graduate School of Business, Certified Professional in Healthcare Risk Management, Fellow of the American College of Healthcare Executives, Patient Safety Officer by the International Board Federation of Safety Managers, Master Black Belt in Lean and Six Sigma Management, Professional in Healthcare Quality by the National Association of Healthcare Quality, Manager for Quality and Organizational Excellence, by the American Society for Quality, and Certified Risk Management Professional by the American Society for Healthcare Risk Management. Additionally, Dr. Vasiliu-Feltes is an Honorary Advisory Board Member of several companies, as well as an Editorial Board Member for several international publications, an author and TV/Media partner.